|
Market Closed -
CBOE
16:00:00 08/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 8,641.79 HUF | 0.00% |
|
0.00% | +1.07% |
| 09-18 | EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug | MT |
| 08-11 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 |
| Market Cap | 2,225B 6.81B 6.08B 5.67B 5.15B 9.7B 660B 9.79B 68.11B 26.64B 335B 25.57B 25.01B 1,078B | P/E 2026 * |
8.98x | P/E 2027 * | 7.68x |
|---|---|---|---|---|---|
| Enterprise Value | 1,963B 6.01B 5.36B 5B 4.55B 8.55B 582B 8.64B 60.07B 23.5B 296B 22.55B 22.06B 951B | EV / Sales 2026 * |
2.06x | EV / Sales 2027 * | 1.78x |
| Free-Float |
72.87% | Yield 2026 * |
4.95% | Yield 2027 * | 5.55% |
| Markets | Quality | ||
|---|---|---|---|
Budapest S.E.
| RICHTER | Delayed | |
CBOE
| Real-time | ||
|
OTC Markets
| RGEDF | Delayed | |
|
Boerse Muenchen
| RIG2 | Real-time | |
|
Deutsche Boerse AG
| RIG2 | Delayed | |
|
London S.E.
| 0QFP | Delayed | |
|
CBOE
| 0QFP | Real-time | |
|
Börse Stuttgart
| RIG2 | Delayed |
Last Transcript: Gedeon Richter PLC
| 6 months | +1.07% | ||
| Current year | +1.07% |
| 1 week | 8,641.79 |  | 8,641.79 |
| 1 month | 8,641.79 | | 8,641.79 |
| 3 years | 8,041 | | 9,720 |
| 5 years | 8,041 | | 9,720 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gábor Orbán
CEO | Chief Executive Officer | 47 | 31/10/2017 |
| Director of Finance/CFO | - | 30/04/2025 | |
Attila Szénási
COO | Chief Operating Officer | - | 31/12/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Erik Bogsch
CHM | Chairman | 79 | 31/12/2016 |
Szilveszter Vizi
CHM | Chairman | 90 | 29/02/2024 |
| Director/Board Member | 65 | 25/04/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | +1.07% | +1.07% | 6.81B | |
| -1.61% | +1.72% | +38.30% | +106.93% | 1,043B | |
| -0.76% | -0.84% | +35.21% | +62.70% | 618B | |
| +0.39% | +4.81% | +17.81% | +83.77% | 481B | |
| -0.29% | -0.99% | +64.79% | +37.06% | 351B | |
| -2.03% | +1.06% | +21.08% | +42.16% | 338B | |
| -1.92% | -0.29% | +10.54% | +33.20% | 269B | |
| -2.36% | -1.16% | -7.14% | +8.68% | 244B | |
| -1.37% | +0.04% | +38.29% | +52.33% | 220B | |
| +0.17% | -0.27% | +24.40% | +96.82% | 182B | |
| Average | -1.07% | +0.28% | +24.43% | +52.47% | 416.3B | |
| Weighted average by Cap. | -1.04% | +0.60% | +30.41% | +68.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 951B 2.91B 2.6B 2.43B 2.2B 4.15B 282B 4.19B 29.12B 11.39B 143B 10.93B 10.69B 461B | 1,021B 3.12B 2.79B 2.6B 2.36B 4.45B 303B 4.49B 31.25B 12.22B 154B 11.73B 11.47B 494B |
| Net income | 254B 778M 695M 648M 589M 1.11B 75.37B 1.12B 7.78B 3.04B 38.3B 2.92B 2.86B 123B | 291B 889M 794M 741M 673M 1.27B 86.12B 1.28B 8.89B 3.48B 43.76B 3.34B 3.27B 141B |
| Net Debt | -262B -803M -717M -669M -608M -1.14B -77.79B -1.15B -8.03B -3.14B -39.53B -3.02B -2.95B -127B | -410B -1.25B -1.12B -1.05B -950M -1.79B -122B -1.8B -12.55B -4.91B -61.75B -4.71B -4.61B -199B |
| Date | Price | Change |
|---|---|---|
| 08/10/26 | HUF 8,641.79 | +30.04% |
| 07/10/26 | HUF 6,645.59 | 0.00% |
| 06/10/26 | HUF 6,645.59 | 0.00% |
| 05/10/26 | HUF 6,645.59 | 0.00% |
| 02/10/26 | HUF 6,645.59 | 0.00% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RICHTER Stock
- 0QFP Stock
Select your edition
All financial news and data tailored to specific country editions
